Michal Šála

1.4k total citations
58 papers, 1.1k citations indexed

About

Michal Šála is a scholar working on Molecular Biology, Infectious Diseases and Organic Chemistry. According to data from OpenAlex, Michal Šála has authored 58 papers receiving a total of 1.1k indexed citations (citations by other indexed papers that have themselves been cited), including 36 papers in Molecular Biology, 17 papers in Infectious Diseases and 13 papers in Organic Chemistry. Recurrent topics in Michal Šála's work include Biochemical and Molecular Research (12 papers), DNA and Nucleic Acid Chemistry (10 papers) and HIV/AIDS drug development and treatment (9 papers). Michal Šála is often cited by papers focused on Biochemical and Molecular Research (12 papers), DNA and Nucleic Acid Chemistry (10 papers) and HIV/AIDS drug development and treatment (9 papers). Michal Šála collaborates with scholars based in Czechia, Belgium and United States. Michal Šála's co-authors include Radim Nencka, Hubert Hřebabecký, Martin Dračínský, Milan Dejmek, Evžen Bouřa, Eliška Procházková, Johan Neyts, Antonı́n Holý, Helena Mertlíková‐Kaiserová and Daniel Růžek and has published in prestigious journals such as Nucleic Acids Research, The Journal of Physical Chemistry B and Cancer Research.

In The Last Decade

Michal Šála

57 papers receiving 1.0k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Michal Šála Czechia 19 482 263 243 177 127 58 1.1k
Milan Dejmek Czechia 17 384 0.8× 225 0.9× 110 0.5× 119 0.7× 102 0.8× 48 797
Hubert Hřebabecký Czechia 18 656 1.4× 472 1.8× 466 1.9× 154 0.9× 223 1.8× 104 1.2k
T.C. Appleby United States 22 775 1.6× 361 1.4× 276 1.1× 72 0.4× 272 2.1× 29 1.5k
Eva‐María Priego Spain 22 604 1.3× 128 0.5× 601 2.5× 129 0.7× 63 0.5× 51 1.3k
Maria Bretner Poland 25 1.1k 2.2× 270 1.0× 630 2.6× 133 0.8× 125 1.0× 82 1.9k
John R. Somoza United States 20 765 1.6× 136 0.5× 211 0.9× 88 0.5× 170 1.3× 35 1.2k
R. K. ROBINS United States 22 757 1.6× 397 1.5× 343 1.4× 170 1.0× 348 2.7× 73 1.5k
Anders Poulsen Singapore 26 1.2k 2.4× 155 0.6× 399 1.6× 136 0.8× 154 1.2× 56 2.0k
Noriaki Minakawa Japan 26 1.7k 3.4× 418 1.6× 662 2.7× 64 0.4× 299 2.4× 130 2.4k
Charles A. McWherter United States 27 960 2.0× 183 0.7× 170 0.7× 86 0.5× 298 2.3× 55 1.6k

Countries citing papers authored by Michal Šála

Since Specialization
Citations

This map shows the geographic impact of Michal Šála's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Michal Šála with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Michal Šála more than expected).

Fields of papers citing papers by Michal Šála

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Michal Šála. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Michal Šála. The network helps show where Michal Šála may publish in the future.

Co-authorship network of co-authors of Michal Šála

This figure shows the co-authorship network connecting the top 25 collaborators of Michal Šála. A scholar is included among the top collaborators of Michal Šála based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Michal Šála. Michal Šála is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Chalupská, Dominika, Milan Dejmek, Michal Šála, et al.. (2024). Discovery of highly potent SARS-CoV-2 nsp14 methyltransferase inhibitors based on adenosine 5′-carboxamides. RSC Medicinal Chemistry. 15(10). 3469–3476. 5 indexed citations
2.
Řezníčková, Eva, Radek Jorda, Milan Dejmek, et al.. (2023). Inhibition of FLT3-ITD Kinase in Acute Myeloid Leukemia by New Imidazo[1,2-b]pyridazine Derivatives Identified by Scaffold Hopping. Journal of Medicinal Chemistry. 66(16). 11133–11157. 8 indexed citations
3.
Čermáková, Kateřina, Ling Tao, Milan Dejmek, et al.. (2023). Reactivation of the G1 enhancer landscape underlies core circuitry addiction to SWI/SNF. Nucleic Acids Research. 52(1). 4–21. 5 indexed citations
4.
Chalupská, Dominika, Karel Chalupský, Petra Krafčíková, et al.. (2023). Rational Design of Highly Potent SARS-CoV-2 nsp14 Methyltransferase Inhibitors. ACS Omega. 8(30). 27410–27418. 13 indexed citations
5.
Čermáková, Kateřina, Yuen San Chan, Milan Dejmek, et al.. (2023). SWI/SNF Blockade Disrupts PU.1-Directed Enhancer Programs in Normal Hematopoietic Cells and Acute Myeloid Leukemia. Cancer Research. 83(7). 983–996. 21 indexed citations
6.
Hercík, Kamil, Dominika Chalupská, Milan Dejmek, et al.. (2023). Exploring positions 6 and 7 of a quinazoline-based scaffold leads to changes in selectivity and potency towards RIPK2/3 kinases. European Journal of Medicinal Chemistry. 260. 115717–115717. 1 indexed citations
7.
Šála, Michal, et al.. (2023). Hydrogen-Bonding Interactions of 8-Substituted Purine Derivatives. ACS Omega. 8(28). 25538–25548. 2 indexed citations
8.
Klíma, Martin, Dominika Chalupská, Milan Dejmek, et al.. (2022). Structure-based design and modular synthesis of novel PI4K class II inhibitors bearing a 4-aminoquinazoline scaffold. Bioorganic & Medicinal Chemistry Letters. 76. 129010–129010. 5 indexed citations
9.
Blahut, Jan, et al.. (2022). The hydrogen bond continuum in solid isonicotinic acid. Journal of Magnetic Resonance. 345. 107334–107334. 8 indexed citations
10.
Dejmek, Milan, Eva Konkoľová, Luděk Eyer, et al.. (2021). Non-Nucleotide RNA-Dependent RNA Polymerase Inhibitor That Blocks SARS-CoV-2 Replication. Viruses. 13(8). 1585–1585. 27 indexed citations
11.
Kaiser, Martin, Martin Dračínský, Aleš Marek, et al.. (2021). Synthesis and Biological Evaluation of Phosphoester and Phosphorothioate Prodrugs of STING Agonist 3′,3′-c-Di(2′F,2′dAMP). Journal of Medicinal Chemistry. 64(11). 7596–7616. 32 indexed citations
12.
Konkoľová, Eva, Milan Dejmek, Hubert Hřebabecký, et al.. (2020). Remdesivir triphosphate can efficiently inhibit the RNA-dependent RNA polymerase from various flaviviruses. Antiviral Research. 182. 104899–104899. 48 indexed citations
13.
Pohl, Radek, et al.. (2018). The Control of the Tautomeric Equilibrium of Isocytosine by Intermolecular Interactions. European Journal of Organic Chemistry. 2018(37). 5128–5135. 10 indexed citations
14.
Pohl, Radek, et al.. (2018). Proton transfer in guanine–cytosine base pair analogues studied by NMR spectroscopy and PIMD simulations. Faraday Discussions. 212(0). 331–344. 35 indexed citations
15.
Šála, Michal, Martin Kögler, Hubert Hřebabecký, et al.. (2016). Purine analogs as phosphatidylinositol 4-kinase IIIβ inhibitors. Bioorganic & Medicinal Chemistry Letters. 26(11). 2706–2712. 13 indexed citations
16.
Šála, Michal, Milan Dejmek, Hubert Hřebabecký, et al.. (2016). 9-Norbornyl-6-chloropurine (NCP) induces cell death through GSH depletion-associated ER stress and mitochondrial dysfunction. Free Radical Biology and Medicine. 97. 223–235. 23 indexed citations
17.
Hřebabecký, Hubert, et al.. (2014). Transport mechanisms of a novel antileukemic and antiviral compound 9-norbornyl-6-chloropurine. Journal of Enzyme Inhibition and Medicinal Chemistry. 30(1). 57–62. 2 indexed citations
18.
Dejmek, Milan, Hubert Hřebabecký, Michal Šála, et al.. (2014). From norbornane-based nucleotide analogs locked in South conformation to novel inhibitors of feline herpes virus. Bioorganic & Medicinal Chemistry. 22(11). 2974–2983. 16 indexed citations
19.
Dejmek, Milan, Michal Šála, Hubert Hřebabecký, et al.. (2014). Norbornane-based nucleoside and nucleotide analogues locked in North conformation. Bioorganic & Medicinal Chemistry. 23(1). 184–191. 17 indexed citations
20.
Šála, Michal, Hubert Hřebabecký, Pieter Leyssen, et al.. (2012). Novel substituted 9-norbornylpurines and their activities against RNA viruses. Bioorganic & Medicinal Chemistry Letters. 22(5). 1963–1968. 7 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Milan Dejmek Breakdown of academic impact, for papers by Hubert Hřebabecký Breakdown of academic impact, for papers by T.C. Appleby Breakdown of academic impact, for papers by Eva‐María Priego Breakdown of academic impact, for papers by Maria Bretner Breakdown of academic impact, for papers by John R. Somoza Breakdown of academic impact, for papers by R. K. ROBINS Breakdown of academic impact, for papers by Anders Poulsen Breakdown of academic impact, for papers by Noriaki Minakawa Breakdown of academic impact, for papers by Charles A. McWherter
Rankless by CCL
2026